Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public
- PMID: 38142801
- PMCID: PMC10947872
- DOI: 10.1016/j.josat.2023.209276
Differences in perceptions of community stigma towards opioid use disorder between community substance use coalition members and the general public
Abstract
Introduction: To examine differences in perceptions about community stigma towards individuals with opioid use disorder (OUD) between community members involved in the opioid response (i.e., coalition members) and the general public, and how community geography may moderate this relationship.
Methods: This study administered identical cross-sectional surveys about perceived community opioid-related stigma to two distinct populations in 66 communities participating in the HEALing Communities Study prior to the intervention period (i.e., coalition members, November 2019-January 2020; residents, March-April 2020). Linear-mixed models compared survey responses of populations, including the moderating effect of community rural/urban location.
Results: A total of 826 coalition members and 1131 residents completed the surveys. The study found no differences between the coalition members and residents for general perceived community opioid-related stigma. In both urban and rural communities, coalition members reported greater perceived community stigma than residents reported towards medication for opioid use disorder (MOUD), naloxone, and drug treatment as an alternative to incarceration.
Conclusion: Our findings suggest similar perceived community opioid-related stigma between coalition members and residents, yet differences emerge related to evidence-based practices (i.e., MOUD, naloxone, and drug treatment as an alternative to incarceration) to reduce opioid overdose deaths.
Trial registration: ClinicalTrials.gov Identifier: NCT04111939.
Keywords: Community coalitions; Drug treatment; MOUD; Naloxone; Opioid use disorder; Stigma.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest Daniel Walker reports financial support was provided by The Ohio State University College of Medicine. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
-
- Beaugard CA, Hruschak V, Lee CS, Swab J, Roth S, & Rosen D (2022). Emergency medical services on the frontlines of the opioid overdose crisis: The role of mental health, substance use, and burnout. International Journal of Emergency Services. 10.1108/IJES-11-2021-0073 - DOI
-
- Benjamini Y, & Hochberg Y (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society: Series B (Methodological), 57(1), 289–300. 10.1111/j.2517-6161.1995.tb02031.x - DOI
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
